Cargando…
Maximum Efficacy of Mesenchymal Stem Cells in Rat Model of Renal Ischemia-Reperfusion Injury: Renal Artery Administration with Optimal Numbers
BACKGROUNDS: Despite the potential therapeutic benefits, cell therapy in renal ischemia-reperfusion (I/R) injury is currently limited by low rates of cell engraftment after systemic delivery. In this study, we investigate whether locally administration through renal artery can enhance the migration...
Autores principales: | Cai, Jieru, Yu, Xiaofang, Xu, Rende, Fang, Yi, Qian, Xiaoqin, Liu, Shaopeng, Teng, jie, Ding, Xiaoqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956922/ https://www.ncbi.nlm.nih.gov/pubmed/24637784 http://dx.doi.org/10.1371/journal.pone.0092347 |
Ejemplares similares
-
Correction: Maximum Efficacy of Mesenchymal Stem Cells in Rat Model of Renal Ischemia-Reperfusion Injury: Renal Artery Administration with Optimal Numbers
Publicado: (2014) -
Mesenchymal stromal cells in renal ischemia/reperfusion injury
por: de Vries, Dorottya K., et al.
Publicado: (2012) -
Administration of mesenchymal stromal cells before renal ischemia/reperfusion attenuates kidney injury and may modulate renal lipid metabolism in rats
por: Erpicum, Pauline, et al.
Publicado: (2017) -
Crosstalk between gut microbiota and renal ischemia/reperfusion injury
por: Huang, Peng, et al.
Publicado: (2022) -
The optimal duration of ischemic preconditioning for renal ischemia-reperfusion injury in mice
por: Choi, Hyun Su, et al.
Publicado: (2017)